Co-director of Bioquant and Professor of Protein Evolution at Heidelberg University. Previously Group Leader at EMBL, Heidelberg, Academic Editor at FEBS Letters at PLoS Computational Biology.
Dr. Rajesh Kumar Singh received his BPharm (2003) and MPharm (2005) from UIPS, Panjab University, Chandigarh. He started to teach pharmaceutical chemistry at the Shivalik College of Pharmacy, Nangal, in 2006, where he completed his PhD in 2013 from IKG Punjab Technical University (IKGPTU), Jalandhar. His major areas of research interest are computer-aided drug-design, polymer-drug conjugates for targeted delivery to CNS and cancerous cells, antimalarial therapeutic agents, and green chemistry approaches for chemical synthesis. Dr. Singh has over 15 years of teaching experience and has guided one 03 Ph.D. and 20 PG students. He is currently guiding 02 PhDs and 02 MPharm students. He has published more than 70 peer-reviewed SCI/SCOPUS-indexed scientific papers with a total JCR Impact Factor of more than 200 in various chemistry and pharmacy journals such as European Journal of Medicinal Chemistry, Acta Pharmaceutica Sinica-B, Bioorganic Chemistry, Biomedicine and Pharmacotherapy, Pharmaceutical Research, European Journal of Pharmaceutical Sciences, Mini-Reviews in Medicinal Chemistry, Pharmaceutical Research, Med. Chem. Res., J. Enzyme Inhi. Med Chem., Res. Chem. Intermediate etc as main or corresponding author. He currently serves as an Editorial Advisory Board Member of 10 international journals, including the SCI-indexed MRMC (Bentham) and PeerJ. He has received the Publon Award 2016, 2017 and the Publon "Excellent Peer Reviewer Award" for outstanding reviewing of more than 290 research papers in different international journals of ACS, RSC, Springer, Elsevier, Dove, Informa, and Bentham whose Impact Factor varies from 1.0 to 12.5. He also has over 60 National and International Conference Abstracts, 5 Books, 5 Best Paper Presentation Awards, 1 Travel Grant to attend International Conferences, and 5 Research Projects funded by Indian Government Agencies. He is also on the panel of international reviewers for research proposals for Royal Society Grants. He is also serving as a PUBLON ACADEMY MENTOR and a BENTHAM BRAND AMBASSADOR. He has been recognized by the Editors as an OUTSTANDING REVIEWER for RSC Medicinal Chemistry journal (IF 4.1, Q1) and also for BENTHAM PUBLISHER in 2023. His name is recently featured in the list of top 2% scientists (2023) ranked by team of Stanford University, USA and Elsevier.
Professor of Chemistry, and Director of the Program in Bioinformatics, Boston University. Elected Fellow of the AAAS. Recipient of the Herbert A. Sober Award of the ASBMB. Research interests include developing new chemical probe methods (in particular, hydroxyl radical footprinting) for determining the structure of DNA, RNA, and DNA-protein complexes.
Dr. Shibiao Wan is currently an Assistant Professor in the Department of Genetics, Cell Biology and Anatomy, and the Co-Director for the Bioinformatics and Systems Biology (BISB) PhD Program at University of Nebraska Medical Center (UNMC). He is also an Assistant Professor (courtesy) in the Department of Biostatistics at UNMC.
With more than 15 years of experience in machine learning, bioinformatics, and computational biology, Dr. Wan has published >60 articles in top-tiered journals such as Genome Research, Nature Communications, Science Advances, Circulation Research, Briefings in Bioinformatics, and Bioinformatics. Dr. Wan is the Editor-in-Chief for Current Proteomics, and an Associate Editor/Academic Editor/Editorial Board Member for a series of prestigious journals such as Briefings in Functional Genomics, Heliyon, BMC Bioinformatics, International Journal of Microbiology, PeerJ Computer Science, BioMed Research International, and Computational and Mathematical Methods, and a guest associate editor for multiple high-impact journals.
He is a Scientific Program Committee (SPC) member for American Medical Informatics Association (AMIA) Annual Symposium and a Technical Program Committee (TPC) member for >20 machine learning related international conferences including IEEE ICTAI. Dr. Wan is also a reviewer for >70 prestigious journals including Nature Biotechnology, Nature Methods, Nature Communications, Nature Computational Science, Science Advances, Nucleic Acids Research, Advanced Science, Cancer Research, Genome Biology, and Genome Medicine. Dr. Wan has received a number of accolades including the Springer Nature Editor of Distinction Award in 2025 by Springer Nature, the New Investigator Award in 2024 by UNMC, the FIRST Award in 2023 by Nebraska EPSCoR, the Outstanding Young Alumni Award in 2022 by HK PolyU as well as the Global Peer Review Awards (top 1%) in “Cross-Field” and “Biology and Biochemistry” in 2019 by Clarivate. Dr. Wan is a member of AACR, AMIA, ISCB and ACM and an IEEE Senior Member.
Professor of Biology in the Department of Molecular Biology, Cellular Biology, and Biochemistry at Brown University.
Prof. Dr. Michael Wink is Professor of Biology and Director at the Institute of Pharmacy and Molecular Biotechnology of Heidelberg University; Head of Biology Department (1989-2019). Senior professor since 2019. Editor of Diversity, Biotechnology Journal and Journal of Ornithology. Member of several editorial boards and scientific societies. Author of over 20 books and over 900 original peer-reviewed publications.
I am a broadly-trained microbiologist with a research background in molecular biology, microbial ecology, genomics and biogeochemistry. Over the past 12 years I have served as a Staff Scientist within the Department of Energy National Laboratory system, first in the Environmental Biotechnology Section at Savannah River National Laboratory (2005-2011) and then in the Biosciences and Chemistry Divisions at Los Alamos National Laboratory (2011-current). As a staff scientist, I developed and managed a variety of research programs, focusing on microbial communities involved in processes relevant to climate change, fate and transport of radionuclides in the environment and bioenergy production. I received a BS degree from the University of Wyoming in Biochemistry, after which I worked as a laboratory technologist at the University of Utah and the VA medical center in Salt Lake City, UT with a team investigating the molecular underpinnings of diabetes. I received my doctorate in Cellular and Molecular Biology at Oregon State University in 2001 under Drs. Daniel Arp and Peter Bottomley investigating biodegradation of toxic compounds, such as trichloroethylene and toluene, by soil microorganisms. I completed postdoctoral training (2001-2004) at Los Alamos National Laboratory under Dr. Cheryl Kuske examining how the microorganisms that build and maintain biocrusts in soils of arid environments might respond to climate change.
I’m Project Scientist at University of California, Davis. My research interests focus on developing novel chemoenzymatic methods for efficient synthesis of biologically important complex carbohydrates and glycoconjugates; exploring substrate specificities of glycosyltransferases and other carbohydrate biosynthetic enzymes; as well as analyzing, purifying, and characterizing carbohydrates and glycoconjugates.